I'm LongbridgeAI, I can summarize articles.CMB International Securities analyst Jill Wu maintained a Buy rating on Akeso, Inc. today and set a price target of HK$99.34.
Wu covers the Healthcare sector, focusing on stocks such as Innovent Biologics, Hansoh Pharmaceutical Group Company Limited, and Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H. According to TipRanks, Wu has an average return of 23.5% and a 52.97% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Akeso, Inc. with a HK$152.82 average price target.
